PATENT CLAIM ANALYSIS

Application Number: 16020531
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["514", "017700"]

Abstract:
Polypeptides including Neurochondrin and autoantibodies binding to polypeptides including Neurochondrin are provided. Methods for diagnosing or treating diseases associated with neurological symptoms or cancers are also provided. The methods of diagnosis may include detecting an autoantibody binding to Neurochondrin in a sample from a patient. The methods of treatment may include administering a polypeptide comprising Neurochondrin to a patient.

Claim (Index 35):
The method of  claim 26 , wherein the bodily fluid is selected from the group comprising cerebrospinal fluid, whole blood, blood serum, lymph, interstitial fluid, and saliva.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 94.0
- Lexical Diversity: 1.53659
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15078361', '15954019', '14822045', '15172450', '14000221']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6838312090046895
- 35 USC 102 Novelty (BERT): 0.5239230142394736
- Combined Prediction Score: 0.6678403895281679
- Mean Citation Score: 238.06573000000003
- Max Citation Score: 311.9436
- Similarity Product: 236.3406157218933

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test